ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
엠브렐(Enbrel) 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 연간 평균 성장률(CAGR) 6%로 성장할 전망이며, 209억 3,090만 달러로 성장이 예측됩니다. 이 예측 기간 동안의 성장은 복수의 적응증에 있어서의 엠브렐 사용 확대, 생물제제 및 류마티스 관절염(ra) 치료에 대한 정부 지원의 증가, 자가면역 질환에 대한 의식 고조, 일반 인구에서 염증성 질환에 대한 의식의 고조, 바이오시밀러의 이용 가능성 증가, 엠브렐 인지 촉진 등에 기인하고 있습니다. 예측 기간 주요 동향으로는 자가면역 질환 관리를 위한 디지털 헬스케어 도구, 제약기업 간 세계적 파트너십, 환자 컴플라이언스 향상을 위한 장시간 작용형 주사제제 개발, 자가면역질환 치료 개발에 있어 인공지능 통합, 생물제제 대체 배달 시스템 개발 등을 들 수 있습니다.
자가면역 질환의 유병률 증가는 엠브렐(Enbrel) 시장의 확대를 촉진할 것으로 예측됩니다. 자가면역 질환은 면역계가 실수로 신체의 건강한 세포나 조직을 공격하여 염증이나 다양한 장기에 손상을 일으키면서 발생합니다. 이러한 유병률의 증가는 유전적 소인, 환경적 유인, 라이프스타일 및 면역계 행동의 변화 등의 요인과 관련되어 있습니다. 자가면역증례의 증가는 류마티스 관절염이나 건선성 관절염과 같은 염증성 질환을 관리하는 엠브렐과 같은 치료에 대한 수요를 끌어올리고 있습니다. 예를 들어, 2022년 8월 국립의료도서관은 코로나19 백신 접종과 관련된 자가면역 질환 사례를 약 928례 보고하였습니다. 이 중 81.5%(756예)는 새로 발병한 자가면역 질환으로 증상은 보통 백신 접종 후 8일째에 나타났습니다. 여성은 증례의 53.6%를 차지했고, 연령 중앙값은 48세였습니다. 이처럼 자가면역 질환 유병률 증가는 엠브렐 시장을 전진시킬 것으로 예측됩니다.
엠브렐(Enbrel) 시장의 중요한 동향은 경쟁을 강화하기 위해 약사 승인을 받는 것입니다. 의약품 승인 과정에서는 규제 당국이 임상검사 데이터를 기반으로 신약의 안전성, 유효성, 품질을 평가하고 승인합니다. 예를 들어, 2023년 10월 미국 바이오의약품 회사인 Amgen Inc.는 활동성 조기 건선성 관절염(JPsA)의 2세 이상 소아 치료를 위해 엔브렐 FDA 승인을 발표했습니다. 이 승인은 성인의 관절염성 건선(PsA), 류마티스 관절염(RA), 건선 환자를 대상으로 한 포괄적인 안전성 및 유효성 검사를 통해 실증된 종양괴사인자 차단제로서의 에타넬셉트의 독특한 특성을 강조하는 것입니다. 또한 활동성 조기성 관절염(JIA)과 건선 소아 환자에서의 사용을 지지하는 약제동태학적(PK) 데이터도 포함되어 있습니다. 조기 발병성 관절염(JPsA)에 대한 권장 용량은 체중 기반이며 주 1회 피하주사로 투여합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 바이오의약품 시장에서의 제품 특성
분자 유형
투여 경로(ROA)
작용기전(MOA)
안전성 및 유효성
제4장 시장 동향 및 전략
제5장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나연 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제6장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 상징: PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 상징 시장 : 성장률 분석
세계의 엠브렐(Enbrel) 시장 실적 : 규모 및 성장(2019-2024년)
세계의 엠브렐(Enbrel) 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 상징 : 전체 시장 규모(TAM)
제7장 세계의 가격 분석 및 예측
제8장 시장 세분화
세계의 엠브렐(Enbrel) 시장 : 제품별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
주사액
프리필드 주사기
병용 요법
서방형 제제
바이오시밀러
세계의 엠브렐(Enbrel) 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
세계의 엠브렐(Enbrel) 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
류마티스 관절
청소년 특발성 관절염
건선성 관절염
강직성 척추염
기타
제9장 세계의 임상적응증 역학
약제의 부작용
임상적응증의 발병률 및 유병률
제10장 지역별 및 국가별 분석
세계의 엠브렐(Enbrel) 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 엠브렐(Enbrel) 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 경쟁 구도 및 기업 프로파일
엠브렐(Enbrel) 시장 : 경쟁 구도
엠브렐(Enbrel) 시장 : 기업 프로파일
Amgen Inc.
제29장 세계 시장 : 파이프라인 분석
제30장 세계 시장 경쟁 벤치마킹 및 대시보드
제31장 주요 인수합병(M&A)
제32장 최근 시장 동향
제33장 시장의 잠재력이 높은 국가, 부문 및 전략
엠브렐(Enbrel) 시장(2029년) : 새로운 기회를 제공하는 국가
엠브렐(Enbrel) 시장(2029년) : 새로운 기회를 제공하는 부문
엠브렐(Enbrel) 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제34장 부록
AJY
영문 목차
영문목차
Enbrel (generic name: etanercept) is a prescription drug used to manage various autoimmune disorders by suppressing the immune system. This biologic medication functions by blocking tumor necrosis factor (TNF), a substance that contributes to inflammation in conditions like rheumatoid arthritis and psoriasis.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Enbrel is available in several forms, including injectable solutions, prefilled syringes, combination therapies, extended-release formulations, and biosimilars. Injectable solutions are liquid medications administered via injection. These products are distributed through hospital pharmacies, retail pharmacies, and online pharmacies and are used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and other related conditions.
The enbrel market research report is one of a series of new reports from The Business Research Company that provides enbrel market statistics, including enbrel industry global market size, regional shares, competitors with a enbrel market share, detailed enbrel market segments, market trends and opportunities, and any further data you may need to thrive in the enbrel industry. This enbrel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The enbrel market size is expected to see strong growth in the next few years. It will grow to $20,930.9 million in 2029 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to growing use of enbrel in multiple indications, increasing government support for biologics and rheumatoid arthritis (ra) treatment, growing awareness of autoimmune diseases, rising awareness of inflammatory diseases in the general population, increasing availability of biosimilars, promoting awareness of enbrel. Major trends in the forecast period include digital healthcare tools for managing autoimmune diseases, global partnerships between pharmaceutical companies, development of long-acting injectable formulations for better patient compliance, integration of artificial intelligence in drug development for autoimmune diseases, development of alternative delivery systems for biologic drugs.
The growing prevalence of autoimmune conditions is anticipated to fuel the expansion of the Enbrel market. Autoimmune conditions arise when the immune system erroneously attacks the body's healthy cells and tissues, causing inflammation and damage to various organs. This increasing prevalence is linked to factors such as genetic predisposition, environmental triggers, and lifestyle or immune system behavior changes. The rising number of autoimmune cases boosts the demand for treatments like Enbrel, which manages inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis. For example, in August 2022, the National Library of Medicine reported approximately 928 cases of autoimmune conditions associated with COVID-19 vaccination in 2022. Among these, 81.5% (756 cases) were new-onset autoimmune diseases, with symptoms typically appearing eight days post-vaccination. Women accounted for 53.6% of the cases, with a median age of 48. Thus, the growing prevalence of autoimmune conditions is projected to drive the Enbrel market forward.
A significant trend in the Enbrel market involves obtaining regulatory drug approvals to enhance competitive positioning. Drug approval processes involve regulatory authorities assessing and authorizing new drugs for safety, efficacy, and quality based on clinical trial data. For instance, in October 2023, Amgen Inc., a US-based biopharmaceutical company, announced FDA approval for Enbrel to treat children aged two and older with active juvenile psoriatic arthritis (JPsA). This approval underscores the unique attributes of etanercept as a tumor necrosis factor blocker, demonstrated through comprehensive safety and efficacy studies in adults with psoriatic arthritis (PsA), rheumatoid arthritis (RA), and psoriasis. It also includes pharmacokinetic (PK) data supporting its use in pediatric patients with active juvenile idiopathic arthritis (JIA) and psoriasis. The recommended dosage for juvenile PsA (JPsA) is weight-based and administered via weekly subcutaneous injection.
In November 2023, Amazon Web Services Inc. (AWS), a US-based cloud computing company, partnered with Amgen Inc. to enhance production output and expedite global delivery of medications to patients. Through this collaboration, Amgen is utilizing AWS to develop generative AI-based solutions to accelerate the discovery, development, and manufacturing processes for medicines aimed at treating serious illnesses. Amgen Inc. is a US-based producer of Enbrel.
The key copanies operating in the enbrel market is Amgen Inc.
North America was the largest region in the enbrel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in enbrel report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the enbrel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The enbrel market consists of sales of monoclonal antibodies, cancer immunotherapy drugs and biosimilars. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Enbrel Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on enbrel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for enbrel ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The enbrel market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Application: Rheumatoid Arthritis; Juvenile Idiopathic Arthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Other Applications
Companies Mentioned: Amgen Inc.
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Enbrel Market Characteristics
3. Enbrel Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Enbrel Market Trends And Strategies
5. Enbrel Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
6. Global Enbrel Growth Analysis And Strategic Analysis Framework
6.1. Global Enbrel PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Enbrel Market Growth Rate Analysis
6.4. Global Enbrel Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
6.5. Global Enbrel Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
6.6. Global Enbrel Total Addressable Market (TAM)
7. Global Enbrel Pricing Analysis & Forecasts
8. Enbrel Market Segmentation
8.1. Global Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
Injectable Solution
Prefilled Syringes
Combination Therapy
Extended Release Formulations
Biosimilars
8.2. Global Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
8.3. Global Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Other Applications
9. Global Enbrel Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Enbrel Market Regional And Country Analysis
10.1. Global Enbrel Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
10.2. Global Enbrel Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11. Asia-Pacific Enbrel Market
11.1. Asia-Pacific Enbrel Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.3. Asia-Pacific Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.4. Asia-Pacific Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
12. China Enbrel Market
12.1. China Enbrel Market Overview
12.2. China Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.3. China Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.4. China Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
13. India Enbrel Market
13.1. India Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.2. India Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.3. India Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14. Japan Enbrel Market
14.1. Japan Enbrel Market Overview
14.2. Japan Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.3. Japan Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.4. Japan Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15. Australia Enbrel Market
15.1. Australia Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.2. Australia Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.3. Australia Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16. South Korea Enbrel Market
16.1. South Korea Enbrel Market Overview
16.2. South Korea Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.3. South Korea Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.4. South Korea Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17. Western Europe Enbrel Market
17.1. Western Europe Enbrel Market Overview
17.2. Western Europe Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.3. Western Europe Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.4. Western Europe Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18. UK Enbrel Market
18.1. UK Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.2. UK Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.3. UK Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19. Germany Enbrel Market
19.1. Germany Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.2. Germany Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.3. Germany Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20. France Enbrel Market
20.1. France Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.2. France Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.3. France Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21. Eastern Europe Enbrel Market
21.1. Eastern Europe Enbrel Market Overview
21.2. Eastern Europe Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.3. Eastern Europe Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.4. Eastern Europe Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22. North America Enbrel Market
22.1. North America Enbrel Market Overview
22.2. North America Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.3. North America Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.4. North America Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23. USA Enbrel Market
23.1. USA Enbrel Market Overview
23.2. USA Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.3. USA Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.4. USA Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24. Canada Enbrel Market
24.1. Canada Enbrel Market Overview
24.2. Canada Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.3. Canada Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.4. Canada Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25. South America Enbrel Market
25.1. South America Enbrel Market Overview
25.2. South America Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.3. South America Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.4. South America Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26. Middle East Enbrel Market
26.1. Middle East Enbrel Market Overview
26.2. Middle East Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.3. Middle East Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.4. Middle East Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27. Africa Enbrel Market
27.1. Africa Enbrel Market Overview
27.2. Africa Enbrel Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.3. Africa Enbrel Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.4. Africa Enbrel Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
28. Enbrel Market Competitive Landscape And Company Profiles
28.1. Enbrel Market Competitive Landscape
28.2. Enbrel Market Company Profiles
28.2.1. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
29. Global Enbrel Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Enbrel Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Enbrel Market
32. Recent Developments In The Enbrel Market
33. Enbrel Market High Potential Countries, Segments and Strategies
33.1 Enbrel Market In 2029 - Countries Offering Most New Opportunities
33.2 Enbrel Market In 2029 - Segments Offering Most New Opportunities
